• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4-1BB在免疫反应中的作用。

Role of 4-1BB in immune responses.

作者信息

Vinay D S, Kwon B S

机构信息

Indiana University School of Medicine, and the Walther Oncology Center, 635 Barnhill Drive, Indianapolis, IN, 46202-5120, USA.

出版信息

Semin Immunol. 1998 Dec;10(6):481-9. doi: 10.1006/smim.1998.0157.

DOI:10.1006/smim.1998.0157
PMID:9826581
Abstract

4-1BB is an inducible T cell surface receptor which belongs to the tumor necrosis factor receptor superfamily, a group of cysteine-rich cell-surface molecules. Both human and mouse 4-1BB recently received HLDA nomenclature. Naive T cells lack 4-1BB, which is not only induced upon T cell activation, but also remains on activated T cells. The natural ligand for 4-1BB, 4-1BBL is also induced and is found on activated antigen-presenting cells. Cross-linking of the 4-1BB molecule by agonistic antibody transmits a distinct and potent co-stimulatory signal leading to the activation and differentiation of CD4(+) and CD8(+) cells. 4-1BB transmits signals through the TRAF2-NIK pathway and activates NF-kappaB. Signals relayed through 4-1BB inhibit activation-induced cell death and rescue the immune system during the post-CD28 phase. Antibodies to the 4-1BB molecule can increase GVHD, accelerate the rejection of cardiac allograft and skin transplants, and eradicate established tumors. Interference with the 4-1BB-4-1BBL pathway may be of therapeutic use in the treatment of HIV infection. 4-1BB-deficient mice show dysregulated immune responses and mount elevated Ig responses to T-dependent antigens.

摘要

4-1BB是一种可诱导的T细胞表面受体,属于肿瘤坏死因子受体超家族,该家族是一组富含半胱氨酸的细胞表面分子。人和小鼠的4-1BB最近都获得了HLDA命名。初始T细胞缺乏4-1BB,4-1BB不仅在T细胞活化时被诱导,而且在活化的T细胞上持续存在。4-1BB的天然配体4-1BBL也被诱导,并在活化的抗原呈递细胞上发现。激动性抗体使4-1BB分子交联可传递独特而有效的共刺激信号,导致CD4(+)和CD8(+)细胞活化和分化。4-1BB通过TRAF2-NIK途径传递信号并激活NF-κB。通过4-1BB传递的信号可抑制活化诱导的细胞死亡,并在CD28后阶段拯救免疫系统。针对4-1BB分子的抗体可增加移植物抗宿主病,加速心脏同种异体移植和皮肤移植的排斥反应,并根除已形成的肿瘤。干扰4-1BB-4-1BBL途径可能在治疗HIV感染中具有治疗用途。4-1BB缺陷小鼠表现出免疫反应失调,对T细胞依赖性抗原的Ig反应升高。

相似文献

1
Role of 4-1BB in immune responses.4-1BB在免疫反应中的作用。
Semin Immunol. 1998 Dec;10(6):481-9. doi: 10.1006/smim.1998.0157.
2
Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.阻断4-1BB(CD137)/4-1BB配体相互作用可提高同种异体移植物的存活率。
Transpl Int. 2004 Aug;17(7):351-61. doi: 10.1007/s00147-004-0726-3. Epub 2004 Jul 31.
3
Role of 4-1BB:4-1BB ligand in cancer immunotherapy.4-1BB:4-1BB配体在癌症免疫治疗中的作用。
Cancer Gene Ther. 2004 Mar;11(3):215-26. doi: 10.1038/sj.cgt.7700670.
4
Costimulation of CD28- T lymphocytes by 4-1BB ligand.4-1BB配体对CD28阴性T淋巴细胞的共刺激作用。
J Immunol. 1997 Jan 15;158(2):551-9.
5
Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation.4-1BB抗体对抗肿瘤免疫及肿瘤反应性T细胞生成的不同影响。
Cancer Res. 2001 Mar 1;61(5):2031-7.
6
Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death.通过4-1BB的信号对先前活化的脾T细胞具有共刺激作用,并抑制活化诱导的细胞死亡。
J Immunol. 1997 Mar 15;158(6):2600-9.
7
T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer.全身性激动抗体激活T细胞与局部4-1BB配体基因递送联合白细胞介素-12可根除乳腺癌肝转移。
Gene Ther. 2002 Jun;9(12):786-92. doi: 10.1038/sj.gt.3301687.
8
Potential role of 4-1BB in T cell activation. Comparison with the costimulatory molecule CD28.4-1BB在T细胞活化中的潜在作用。与共刺激分子CD28的比较。
J Immunol. 1995 Oct 1;155(7):3360-7.
9
4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells.活化的CD4+CD25+ T细胞通过4-1BB对免疫抑制的抑制作用
J Leukoc Biol. 2004 May;75(5):785-91. doi: 10.1189/jlb.1003491. Epub 2003 Dec 23.
10
Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-1BB.应激激酶途径在通过T细胞共刺激受体4-1BB进行信号传导中的作用。
J Immunol. 1999 Sep 15;163(6):2990-8.

引用本文的文献

1
High-dimensional single-cell phenotyping unveils persistent differences in immune cell profiles between severe and moderate seasonal influenza.高维单细胞表型分析揭示了重度和中度季节性流感之间免疫细胞谱的持续差异。
Front Immunol. 2025 Jul 22;16:1576861. doi: 10.3389/fimmu.2025.1576861. eCollection 2025.
2
Shared roles of immune and stromal cells in the pathogenesis of human bronchiolitis obliterans syndrome.免疫细胞和基质细胞在人类闭塞性细支气管炎综合征发病机制中的共同作用。
JCI Insight. 2025 Apr 15;10(10). doi: 10.1172/jci.insight.176596. eCollection 2025 May 22.
3
4-1BB Antibodies in Oncology Clinical Trials: A Review.
肿瘤学临床试验中的4-1BB抗体:综述
J Immunother Precis Oncol. 2025 Mar 27;8(2):121-131. doi: 10.36401/JIPO-24-30. eCollection 2025 May.
4
Application of deep learning models on single-cell RNA sequencing analysis uncovers novel markers of double negative T cells.深度学习模型在单细胞RNA测序分析中的应用揭示了双阴性T细胞的新标志物。
Sci Rep. 2024 Dec 28;14(1):31158. doi: 10.1038/s41598-024-82406-7.
5
CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression.套细胞淋巴瘤中 CD163+ 巨噬细胞诱导存活相关通路激活和免疫抑制。
Blood Adv. 2024 Aug 27;8(16):4370-4385. doi: 10.1182/bloodadvances.2023012039.
6
Integrated Bioinformatics Analysis Revealed Immune Checkpoint Genes Relevant to Type 2 Diabetes.综合生物信息学分析揭示了与2型糖尿病相关的免疫检查点基因。
Diabetes Metab Syndr Obes. 2024 Jun 11;17:2385-2401. doi: 10.2147/DMSO.S458030. eCollection 2024.
7
4-1BB immunotherapy: advances and hurdles.4-1BB 免疫疗法:进展与障碍。
Exp Mol Med. 2024 Feb;56(1):32-39. doi: 10.1038/s12276-023-01136-4. Epub 2024 Jan 4.
8
The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease.代谢相关脂肪性肝病中双向免疫交叉对话。
Cell Metab. 2023 Nov 7;35(11):1852-1871. doi: 10.1016/j.cmet.2023.10.009.
9
Fundamental Characterization of Antibody Fusion-Single-Chain TNF Recombinant Proteins Directed against Costimulatory TNF Receptors Expressed by T-Lymphocytes.针对表达于 T 淋巴细胞的共刺激 TNF 受体的抗体融合 - 单链 TNF 重组蛋白的基本特性鉴定。
Cells. 2023 Jun 9;12(12):1596. doi: 10.3390/cells12121596.
10
Targeting CD137 (4-1BB) towards improved safety and efficacy for cancer immunotherapy.针对 CD137(4-1BB)提高癌症免疫治疗的安全性和疗效。
Front Immunol. 2023 Jun 2;14:1208788. doi: 10.3389/fimmu.2023.1208788. eCollection 2023.